Alnylam Pharmace. buy Citigroup Inc.
Start price
19.05.26
/
50%
€248.00
Target price
19.05.27
€326.42
Performance (%)
-2.46%
Price
19.06.26
€241.90
Summary
This prediction is currently active. With a performance of -2.46%, the BUY prediction for Alnylam Pharmace. by Citigroup_Inc_ is down slightly. This prediction currently runs until 19.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Alnylam Pharmace. | -0.982% | -0.982% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by Citigroup_Inc_ for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals (ALNY) is now covered by Citigroup Inc.. They set a "buy" rating and a $380.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€384.10
02.09.25
02.09.25
€498.17
02.09.26
02.09.26
-37.02%
19.06.26
19.06.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€269.40
11.07.25
11.07.25
€346.03
11.07.26
11.07.26
-10.21%
19.06.26
19.06.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€261.50
21.03.25
21.03.25
€323.45
21.03.26
21.03.26
2.98%
22.03.26
22.03.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.40
02.08.24
02.08.24
€313.41
02.08.25
02.08.25
38.64%
03.08.25
03.08.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€225.00
25.06.24
25.06.24
€271.50
25.06.25
25.06.25
23.51%
26.06.25
26.06.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€136.40
16.02.24
16.02.24
€210.72
16.02.25
16.02.25
80.65%
17.02.25
17.02.25